T1	DISO 34 43	hipotonía
#1	AnnotatorNotes T1	C0026827; Muscle hypotonia; Finding
T2	DISO 45 56	decaimiento
#2	AnnotatorNotes T2	C0344315; Depressed mood; Mental or Behavioral Dysfunction
T3	DISO 59 76	perdida de fuerza
#3	AnnotatorNotes T3	C3714552; Weakness; Sign or Symptom
T4	Date 81 93	varios meses
T5	LIVB 128 133	Mujer
#4	AnnotatorNotes T5	C0043210; Woman; Population Group | C0242665; wife; Family Group
T6	Age 137 144	49 años
T7	PROC 146 164	institucionalizada
#5	AnnotatorNotes T7	Institutionalized C0562359
T8	DISO 169 180	dependencia
#6	AnnotatorNotes T8	C0439857; Dependence; Mental or Behavioral Dysfunction | C1510472; Drug Dependence; Mental or Behavioral Dysfunction
T9	DEVI 205 220	silla de ruedas
#7	AnnotatorNotes T9	C0043143; wheelchair; Medical Device
T10	Neg_cue 252 254	No
T11	DISO 255 289	reacciones adversas a medicamentos
#8	AnnotatorNotes T11	Adverse reaction to drug (C0041755)
T12	Negated 255 289	reacciones adversas a medicamentos
T13	DISO 294 341	Esclerosis Múltiple forma secundaria progresiva
#9	AnnotatorNotes T13	Multiple Sclerosis, Secondary Progressive (C0751965)
T14	PROC 372 385	diagnosticada
#10	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	Age 392 399	17 años
T16	PROC 404 415	seguimiento
#11	AnnotatorNotes T16	C0420316; Other follow-up; Health Care Activity
T17	PROC 444 447	RMN
#12	AnnotatorNotes T17	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T18	Date 451 455	2018
T19	DISO 465 491	afectación desmielinizante
#13	AnnotatorNotes T19	Demyelinating Diseases (C0011303)
T20	ANAT 512 526	cordón medular
T21	DISO 552 588	lesiones subcortical insular derecha
T22	ANAT 597 627	subcortical temporal izquierda
T23	PROC 635 646	Tratamiento
#14	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	CHEM 651 666	interferón beta
#15	AnnotatorNotes T24	C0015980; interferon-beta; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance | C0751599; Recombinant Interferon Beta; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T25	CHEM 668 680	mitoxantrona
#16	AnnotatorNotes T25	C0026259; mitoxantrone; Organic Chemical · Pharmacologic Substance
T26	CHEM 682 696	ciclofosfamida
#17	AnnotatorNotes T26	C0010583; cyclophosphamide; Organic Chemical · Pharmacologic Substance
T27	CHEM 699 709	fingolimod
#18	AnnotatorNotes T27	C1699926; fingolimod; Immunologic Factor · Organic Chemical · Pharmacologic Substance
T28	CHEM 729 740	ocrelizumab
#19	AnnotatorNotes T28	C1882138; ocrelizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T29	DISO 744 760	Vejiga espástica
#20	AnnotatorNotes T29	C0877419; Automatic bladder; Pathologic Function
T30	DISO 765 769	ITUs
#21	AnnotatorNotes T30	Urinary tract infection (C0042029)
T31	PROC 788 799	seguimiento
#22	AnnotatorNotes T31	C0420316; Other follow-up; Health Care Activity
T32	DISO 816 835	Doble incontinencia
T33	DISO 839 862	Asma bronquial alérgico
T34	DISO 866 893	Trastorno maníaco-depresivo
#23	AnnotatorNotes T34	C0005586; Bipolar Disorder; Mental or Behavioral Dysfunction
T35	PROC 899 922	ingreso en Salud Mental
T36	Date 926 930	2017
T37	Neg_cue 933 936	sin
T38	PROC 937 948	seguimiento
#24	AnnotatorNotes T38	C0420316; Other follow-up; Health Care Activity
T39	Negated 937 948	seguimiento
T40	PROC 959 970	Tratamiento
#25	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	CHEM 979 989	salmeterol
#26	AnnotatorNotes T41	C0073992; salmeterol; Organic Chemical · Pharmacologic Substance
T42	CHEM 990 1001	fluticasona
#27	AnnotatorNotes T42	C0082607; fluticasone; Organic Chemical · Pharmacologic Substance
T43	Dose 1002 1007	1 inh
T44	Frequency 1007 1012	/12 h
T45	CHEM 1014 1028	levocetiricina
#28	AnnotatorNotes T45	C1174893; levocetirizine; Organic Chemical · Pharmacologic Substance
T46	Dose 1029 1033	5 mg
T47	CHEM 1035 1046	mirtazapina
#29	AnnotatorNotes T47	C0049506; mirtazapine; Organic Chemical · Pharmacologic Substance
T48	Dose 1047 1052	15 mg
T49	CHEM 1054 1064	silodosina
#30	AnnotatorNotes T49	C1870115; silodosin; Organic Chemical · Pharmacologic Substance
T50	Dose 1065 1069	8 mg
T51	CHEM 1071 1083	lormetazepam
#31	AnnotatorNotes T51	C0065185; lormetazepam; Organic Chemical · Pharmacologic Substance
T52	Dose 1084 1088	2 mg
T53	CHEM 1090 1099	espesante
T54	DISO 1104 1114	Enfermedad
#32	AnnotatorNotes T54	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T55	PROC 1124 1130	EXAMEN
#33	AnnotatorNotes T55	C0031809; Physical Examination; Health Care Activity
T56	PROC 1135 1153	Exploración física
#34	AnnotatorNotes T56	C0031809; Physical Examination; Health Care Activity
T57	PROC 1272 1299	Auscultación cardiopulmonar
T58	DISO 1325 1343	debilidad muscular
#35	AnnotatorNotes T58	C0151786; Muscle Weakness; Sign or Symptom
T59	PROC 1348 1371	Pruebas complementarias
#36	AnnotatorNotes T59	C1515980; Ancillary Study; Research Activity
T60	PROC 1375 1377	TA
T61	PROC 1386 1388	FC
T62	PROC 1398 1411	Saturación O2
T63	PROC 1420 1437	Bioquímica sérica
T64	DISO 1451 1464	hipercalcemia
#37	AnnotatorNotes T64	C0020437; Hypercalcemia; Disease or Syndrome
T65	PROC 1495 1498	PTH
#38	AnnotatorNotes T65	C0202159; Parathyroid hormone measurement; Laboratory Procedure
T66	PROC 1570 1581	RMN craneal
T67	Neg_cue 1582 1585	sin
T68	DISO 1593 1601	lesiones
#39	AnnotatorNotes T68	C0221198; Lesion; Finding | C3263723; Traumatic injury; Injury or Poisoning
T69	Negated 1593 1601	lesiones
T70	PROC 1656 1691	ecografía de riñón y vías urinarias
T71	Neg_cue 1692 1695	sin
T72	DISO 1709 1725	cálculos renales
#40	AnnotatorNotes T72	C0022650; Kidney Calculi; Disease or Syndrome | C0392525; Nephrolithiasis; Disease or Syndrome
T73	Negated 1709 1725	cálculos renales
T74	Neg_cue 1726 1728	ni
T75	DISO 1729 1737	adenomas
#41	AnnotatorNotes T75	C0001430; Adenoma; Neoplastic Process
T76	Negated 1729 1737	adenomas
T77	PROC 1741 1768	Gammagrafía de paratiroides
#42	AnnotatorNotes T77	C0860840; Parathyroid scintigraphy; Diagnostic Procedure
T78	PROC 1771 1776	SPECT
#43	AnnotatorNotes T78	C0040399; Tomography, Emission-Computed, Single-Photon; Diagnostic Procedure
T79	PROC 1777 1780	TAC
#44	AnnotatorNotes T79	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T80	Spec_cue 1792 1804	sugerente de
T81	DISO 1805 1828	adenoma de paratiroides
#45	AnnotatorNotes T81	C0154041; Benign neoplasm of parathyroid gland; Neoplastic Process
T82	Speculated 1805 1858	adenoma de paratiroides a nivel retrotiroideo derecho
T83	ANAT 1837 1858	retrotiroideo derecho
T84	PROC 1862 1873	TRATAMIENTO
#46	AnnotatorNotes T84	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T85	Neg_cue 1890 1901	Se descarta
T86	PROC 1905 1927	tratamiento quirúrgico
#47	AnnotatorNotes T86	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T87	Negated 1905 1927	tratamiento quirúrgico
T88	CHEM 1950 1961	Cinalcalcet
T89	Dose 1964 1975	dosis bajas
T90	PROC 1978 1995	Control analítico
T91	LIVB 2012 2029	médico de familia
#48	AnnotatorNotes T91	C1704221; Physicians, Family; Professional or Occupational Group
T92	Duration 2033 2042	4 semanas
T93	DISO 2091 2119	Hiperparatiroidismo primario
#49	AnnotatorNotes T93	C0221002; Hyperparathyroidism, Primary; Disease or Syndrome
T94	ANAT 492 506	supratentorial
T95	PROC 2067 2078	DIAGNÓSTICO
T96	DISO 2127 2155	brote de Esclerosis Múltiple
#50	AnnotatorNotes T96	Multiple sclerosis relapse (C0856120)
T97	Date 971 977	actual
T98	Date 1115 1121	actual
T99	Date 713 724	actualmente
T100	Date 949 955	actual
T102	Observation 169 200	dependencia para todas las ABVD
T103	Quantifier_or_Qualifier 331 341	progresiva
T104	Observation 347 370	actividad incapacitante
T105	Quantifier_or_Qualifier 437 443	última
T106	Quantifier_or_Qualifier 457 464	extensa
T108	Quantifier_or_Qualifier 545 551	nuevas
T109	Result_or_Value 590 593	3mm
T110	Result_or_Value 629 632	5mm
T111	Quantifier_or_Qualifier 770 783	de repetición
T112	Quantifier_or_Qualifier 816 821	Doble
T113	Observation 1157 1176	Buen estado general
T114	Observation 1178 1192	bien hidratada
T115	Observation 1195 1205	perfundida
T116	Observation 1207 1221	normocoloreada
T117	Observation 1223 1241	eupneica en reposo
T118	Observation 1243 1268	hemodinámicamente estable
T119	Result_or_Value 1300 1306	normal
T120	Result_or_Value 1379 1385	125/70
T121	Result_or_Value 1390 1396	80 lpm
T122	Result_or_Value 1413 1417	98%.
T123	Result_or_Value 1468 1478	11.7 mg/dl
T124	Observation 1484 1498	aumento de PTH
T125	Result_or_Value 1502 1513	238.5 pg/ml
T126	Quantifier_or_Qualifier 1586 1592	nuevas
T127	Observation 2048 2063	buena evolución
T129	Patient 128 133	Mujer
T130	History_of 255 289	reacciones adversas a medicamentos
T131	History_of 765 783	ITUs de repetición
T132	History_of 839 862	Asma bronquial alérgico
T133	History_of 866 893	Trastorno maníaco-depresivo
T136	Other 2012 2029	médico de familia
T101	History_of 294 341	Esclerosis Múltiple forma secundaria progresiva
T107	History_of 465 491	afectación desmielinizante
T135	History_of 552 588	lesiones subcortical insular derecha
T137	History_of 744 760	Vejiga espástica
T138	History_of 816 835	Doble incontinencia
T139	Quantifier_or_Qualifier 1935 1946	complejidad
T128	Quantifier_or_Qualifier 2121 2126	Nuevo
